A nurse is educating a client who has a new prescription for digoxin. Which of the following statements should the nurse make?

A. “Ask a friend to dispose of the medication in a dumpster”: This is not a safe or recommended method for disposing of unused medications. Medications can be harmful or fatal if they are ingested by children, pets, or anyone for whom they were not prescribed.

B. “Dispose of unused prescription medications in the original packaging”: While it’s important to keep medications in their original packaging while they’re being used, this is not the best method for disposal. The original packaging often contains personal information that should not be shared, and it does not prevent accidental ingestion.

C. “Crush unused opioids and dispose of them in a sealed plastic bag”: Crushing opioids can be dangerous as it can release a potentially lethal dose of the medication. It’s also not recommended to dispose of medications in the regular trash, even if they’re in a sealed bag, as they could still be accessed by children or pets.

D. “Mix unused medications in coffee grounds before disposing of them”: This is the recommended method for disposing of unused medications at home. By mixing medications with an unpalatable substance like coffee grounds, it discourages anyone from ingesting them. The mixture can then be placed in a sealed plastic bag and thrown away in the regular trash. This method helps to prevent accidental ingestion and protects client privacy.

A. PTT (Partial Thromboplastin Time): While PTT is a laboratory test used to assess the intrinsic pathway of coagulation and is helpful in monitoring heparin therapy, it is not typically used to monitor warfarin therapy. Warfarin primarily affects the extrinsic pathway of coagulation, and its effects are assessed using the PT (Prothrombin Time) or INR (International Normalized Ratio).

B. Total iron-binding capacity: Total iron-binding capacity is a laboratory test used to evaluate iron status in the body and is not relevant to monitoring warfarin therapy. It is used primarily in the diagnosis and management of iron deficiency anemia.

C. WBC (White Blood Cell count): WBC count is a laboratory test used to assess the number of white blood cells in the bloodstream and is not relevant to monitoring warfarin therapy. It is typically used to assess for infection or inflammation.

D. PT (Prothrombin Time): Prothrombin Time (PT) is a laboratory test used to assess the extrinsic pathway of coagulation and is essential in monitoring warfarin therapy. Warfarin inhibits the synthesis of vitamin K-dependent clotting factors, primarily factors II, VII, IX, and X. Monitoring the PT allows healthcare providers to assess the anticoagulant effect of warfarin and adjust the dosage as needed to maintain the desired level of anticoagulation.